Table 4.
Delivery mechanisms for miRNA-based therapies in periodontal regeneration.
| Delivery system | Carrier material | miRNA/Agent loaded | Key features | Outcome | Ref |
|---|---|---|---|---|---|
| NF scaffold | PCL nanofibers | miR-22 mimic, miR-126 mimic | High surface-to-volume ratio; acts like ECM; helps cells stick together | Improves iPSCs’ ability to survive and differentiate into bone cells; increases RUNX2, BGLAP, ALPL, SPARK | (115, 116) |
| Dual-miRNA scaffold | Collagen-nanohydroxyapatite | miR-210 mimic + miR-16 inhibitor | Dual-delivery method; connects bone growth and blood vessel growth | Increase Calcium deposition (10–14 days); 2× bone volume; 2.3× blood vessels | (117) |
| Nanospheres | Magnesium silicate (MSNs) | miR-146a-5p | Dual effects on bone growth and the immune system control | Encourages hDPSC osteogenesis and M2 polarization while stopping the formation of osteoclasts | (122) |
| LNPs | LNPs | miR-27 mimic | Targets SFRP1; activates Wnt signaling | increases ALP, RUNX2, COL1, CD31, CD34, VEGF; 6× new blood vessels; 43.9% reduction in bone loss distance | (123) |
| Hydrogel platform | Photocuring hydrogel | MSN+miR-146a complex | Stimulus-responsive; sustained local release | Confirmed efficacy in the infected mouse mandibular bone defect model | (122) |
| EXO-based hydrogel | EXOs from hucMSCs + hydrogel (exo@H) | let-7f-5p, miR-203-3p | Lyophilized EXOs were mixed into a hydrogel | Less loss of dental bone, periodontal inflammation, and osteoclast count | (124) |
| mRNA-LNP | LNPs | mRNA encoding FGF-2 | Continuous protein production; superior to recombinant protein | Increase Cell proliferation (72h); faster wound closure (88.4% vs 76.1%); 4.5× POSTN expression | (125) |